USX:GRTX - Galera Therapeutics, Inc Galera Therapeutics, Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 9.22    +0.110 (+1.21%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

14 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Dr. J. Mel Sorensen

IPO: 2019-11-07

Headquarters: US

Employees: 38

Homepage

Description

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.